Epitalon

A synthetic tetrapeptide developed in Russia by Vladimir Khavinson. Researched for its effects on telomerase activity, melatonin secretion, and longevity markers. Limited Western clinical data.

What does Epitalon mean in peptide research?

A synthetic tetrapeptide developed in Russia by Vladimir Khavinson. Researched for its effects on telomerase activity, melatonin secretion, and longevity markers. Limited Western clinical data. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.

Why this term matters

Understanding Epitalon is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.

Educational only: This glossary is provided for educational and research-reference purposes only. Nothing on this page constitutes medical advice. Consult licensed healthcare professionals for clinical questions.

Where to learn more

For deeper context, see our peptide research articles: